BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
622 results:

  • 1. Bioaccumulation and health risk assessment of trace elements in Tilapia (Oreochromis mossambicus) from selected inland water bodies.
    Balamanikandan V; Shalini R; Arisekar U; Shakila RJ; Padmavathy P; Sivaraman B; Devanesan S; Sundhar S; AlSalhi MS; Mythili R; Kim W
    Environ Geochem Health; 2024 May; 46(6):187. PubMed ID: 38696018
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
    Fetter T; Fietz S; Bertlich M; Braegelmann C; de Vos-Hillebrand L; Wenzel J; Heine A; Landsberg J; Jansen P
    Front Immunol; 2024; 15():1342845. PubMed ID: 38571955
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.
    Ebrahimi N; Abdulwahid ARR; Mansouri A; Karimi N; Bostani RJ; Beiranvand S; Adelian S; Khorram R; Vafadar R; Hamblin MR; Aref AR
    Cell Mol Life Sci; 2024 Feb; 81(1):106. PubMed ID: 38418707
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B-cell depleted patients with persistent COVID-19.
    Inbar T; Dann EJ; Kerner O; Stern A
    Transfusion; 2024 Mar; 64(3):443-448. PubMed ID: 38327238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
    Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
    Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with cancer.
    Chang H; Marquez J; Chen BK; Kim DM; Cheng ML; Liu EV; Yang H; Zhang L; Sinha M; Cheung A; Kwek SS; Chow ED; Bridge M; Aggarwal RR; Friedlander TW; Small EJ; Anderson M; Fong L
    Cancer Immunol Res; 2024 Apr; 12(4):453-461. PubMed ID: 38276989
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
    Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
    Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients.
    Ko B; Tao K; Brennan L; Rakhade S; Chan CX; Moone JY; Zhu R; Sher A; Wang S; Bracero Y; Fullerton B; McLellan B; Geskin LJ; Saenger YM
    Melanoma Res; 2024 Apr; 34(2):134-141. PubMed ID: 38181115
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
    Ding M; Ran X; Qian S; Zhang Y; Wang Z; Dong M; Yang Z; Wu S; Feng X; Zhang J; Zhu L; Niu S; Zhang X
    Aging (Albany NY); 2023 Dec; 15(24):15360-15381. PubMed ID: 38180104
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
    Ascierto PA; Casula M; Bulgarelli J; Pisano M; Piccinini C; Piccin L; Cossu A; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbe C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Cao MG; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Paone M; Vitale MG; Melero I; Grimaldi AM; Giannarelli D; Dummer R; Sileni VC; Palmieri G
    Nat Commun; 2024 Jan; 15(1):146. PubMed ID: 38167503
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Blood cadmium is associated with increased fracture risk in never-smokers - results from a case-control study using data from the Malmö Diet and cancer cohort.
    Wallin M; Andersson EM; Engström G
    Bone; 2024 Feb; 179():116989. PubMed ID: 38072370
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
    Buldini B; Faggin G; Porcù E; Scarparo P; Polato K; Tregnago C; Varotto E; Rizzardi P; Rizzari C; Locatelli F; Biffi A; Pigazzi M
    Cytometry A; 2023 Dec; 103(12):1004-1009. PubMed ID: 37876342
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies.
    Gao H; Chang RZ; Chen XP; Zhang WG; Zhang B; Luo X; Ding ZY
    Front Immunol; 2023; 14():1274449. PubMed ID: 37869012
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease.
    Bailey C; Wei Y; Yan J; Huang D; Zhang P; Qi C; Lazarski C; Su J; Tang F; Wong CS; Zheng P; Liu Y; Liu Y; Wang Y
    Cell Rep Med; 2023 Nov; 4(11):101236. PubMed ID: 37827154
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Dynamic Responses of Circulating T Cells After Stereotactic Body Radiation Therapy for bone Metastasis in Patients With Breast cancer.
    Jeon SH; Jang BS; Kim DY; Kim JH; Shin EC; Kim IA
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):790-800. PubMed ID: 37802227
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeted Nanoparticles Based on Alendronate Polyethylene Glycol Conjugated Chitosan for the Delivery of siRNA and Curcumin for bone Metastasized Breast cancer Applications.
    Mushtaq A; Li L; Grøndahl L; A A
    Macromol Biosci; 2024 Feb; 24(2):e2300268. PubMed ID: 37794635
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
    Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
    Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
    Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
    Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma.
    Huang S; Xiong C; Tan K
    Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 32.